Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study.
Jing HeLiang XieLi YuLijun LiuHong XuTao WangYuyang GaoXuedong WangYou DuanHanmin LiuLi DaiPublished in: Clinical proteomics (2022)
Subsequent logistic regression and receiver operating characteristic analysis suggested maternal serum CFHR4 as a promising biomarker of fetal VSD. Further studies are warranted to verify the findings.